(16 days)
No
The document describes image processing and quantification software with workflow improvements, but there is no mention of AI, ML, or related concepts.
No
The device is a software application for viewing and quantifying image data from ultrasound products. It does not directly provide therapy; rather, it aids in the diagnostic process by quantifying cardiac motion.
Yes
This device is designed to quantify image data from ultrasound products, specifically for cardiac motion quantification, which aids healthcare professionals in assessing and understanding physiological conditions. This process of extracting quantitative information from images for clinical assessment falls under the definition of a diagnostic device.
Yes
The device is described as a "software application package" and is available as a "stand-alone product that can function on a standard PC, on board a dedicated workstation, or on-board Philips' ultrasound systems." While it interacts with ultrasound image data, the description focuses solely on the software's functionality for viewing and quantifying this data, without mentioning any proprietary hardware components included as part of the device itself.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The QLAB Quantification Software and its CMQ plug-in are designed to view and quantify image data acquired from ultrasound products. This is an in vivo imaging modality, meaning it is performed on a living patient, not on a sample taken from the body.
- Intended Use: The intended use is for the "on-line and off-line review and quantification of ultrasound studies." This directly relates to analyzing images generated from within the body.
Therefore, while it is a medical device used in healthcare, it does not fit the definition of an In Vitro Diagnostic.
N/A
Intended Use / Indications for Use
QLAB Quantification Software is a software application package. It is designed to view and quantify image data acquired on Philips Medical Systems ultrasound products.
Product codes (comma separated list FDA assigned to the subject device)
LLZ
Device Description
QLAB Quantification software is available either as a stand-alone product that can function on a standard.PC, on board a dedicated workstation, or on-board Philips' ultrasound systems. It can be used by trained healthcare professionals for the on-line and off-line review and quantification of ultrasound studies in healthcare facilities/hospitals. The QLAB Quantification software application package is designed to view and quantify image data acquired on Philips ultrasound products. Cardiac Motion Quantification (CMQ) is a plug-in included in Philips QLAB Quantification software. The CMO plug-in is an application within OLAB intended to provide cardiac motion quantification. OLAB Quantification software is intended for use in healthcare facilities/hospitals by trained healthcare professionals.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Ultrasound
Anatomical Site
Cardiac
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Trained healthcare professionals in healthcare facilities/hospitals.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The CMQ modifications were tested in accordance with Philips verification and validation processes. Verification and validation data support the following nonclinical claims for the modified CMQ software relative to the unmodified CMQ software:
- Improved workflow fewer mouse clicks for typical assessment;
- Improved workflow decreased average time for typical assessment;
- Decreased intra-observer variability of assessments; and
- Decreased inter-observer variability of assessments.
Verification and validation testing concluded that the modified CMQ is safe and effective and introduced no new risks. Verification, validation, and testing activities, where required to establish the performance, functionality, and reliability characteristics of the modified device with respect to the predicate were performed. Testing involved system level tests, performance tests, and safety testing from hazard analysis. Testing performed demonstrates that the QLAB Quantification software with modified CMQ plug-in meets all defined reliability requirements and performance claims.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.2050 Medical image management and processing system.
(a)
Identification. A medical image management and processing system is a device that provides one or more capabilities relating to the review and digital processing of medical images for the purposes of interpretation by a trained practitioner of disease detection, diagnosis, or patient management. The software components may provide advanced or complex image processing functions for image manipulation, enhancement, or quantification that are intended for use in the interpretation and analysis of medical images. Advanced image manipulation functions may include image segmentation, multimodality image registration, or 3D visualization. Complex quantitative functions may include semi-automated measurements or time-series measurements.(b)
Classification. Class II (special controls; voluntary standards—Digital Imaging and Communications in Medicine (DICOM) Std., Joint Photographic Experts Group (JPEG) Std., Society of Motion Picture and Television Engineers (SMPTE) Test Pattern).
0
2120525 el of 2
MAR - 9 2012
Special 510(k) Premarket Notification
QLAB CMQ Plug-in Modifications
510(k) Summary
This summary of safety and effectiveness is provided as part of the Premarket Notification in compliance with 21 CFR. Part 807.92.
1) Submitter's name, address, telephone number, contact person
Philips Ultrasound, Inc. 3000 Minuteman Road Andover, MA 01810-6302 Penny Greco, Regulatory Affairs Specialist Tel: (978) 659-4615 Fax (978) 975-7324 E-mail: penny.greco@philips.com
Date prepared: February 15, 2012
- Name of the device, including the trade or proprietary name if applicable, the common or usual name, and the classification name, if known:
Common/Usual Name: Picture Archiving and Communications Systems Workstation
Proprietary Name: Classification Name: QLAB CMQ Plug-in CFR 892.2050, system, image processing, radiological, 90 LLZ, Class II
3) Substantially Equivalent Devices
Philips Ultrasound believes that the modified QLAB CMQ Plug-in is substantially equivalent to the previously cleared OLAB TMQ Plug-in marketed pursuant to K070792, and K042540. Originally marketed as TMQ, the QLAB CMQ Plug-in was documented in a letter to file as described in QLAB 510(k) K110414.
- Device Description
OLAB Quantification software is available either as a stand-alone product that can function on a standard.PC, on board a dedicated workstation, or on-board Philips' ultrasound systems. It can be used by trained healthcare professionals for the on-line and off-line review and quantification of ultrasound studies in healthcare facilities/hospitals.
The QLAB Quantification software application package is designed to view and quantify image data acquired on Philips ultrasound products. Cardiac Motion Quantification (CMQ) is a plug-in included in Philips QLAB Quantification software.
Page 1 of 2
Philips Ultrasound
1
K120525
Page 2 of 2
Special 510(k) Premarket Notification
QLAB CMO Plug-in Modifications
The CMO plug-in is an application within OLAB intended to provide cardiac motion quantification. OLAB Quantification software is intended for use in healthcare facilities/hospitals by trained healthcare professionals.
OLAB CMO modifications were implemented to provide clients with improved reproducibility and consistency between users, as well as to provide users with a reduction of workflow steps. The modifications described in this Special 510(k) submission do not alter the intended use of the OLAB Quantification software with the CMO plug-in.
5) Indications for Use
OLAB Ouantification software is a software application package. It is designed to view and quantify image data acquired on Philips Healthcare ultrasound products.
6) Technological characteristics
The OLAB Quantification software with the modified CMQ plug-in has the same technological characteristics as the legally marketed device.
7) Non-clinical performance data
No performance standards for PACS systems or components have been issued under the authority of Section 514. The CMQ modifications were tested in accordance with Philips verification and validation processes. Verification and validation data support the following nonclinical claims for the modified CMQ software relative to the unmodified CMQ software:
- Improved workflow fewer mouse clicks for typical assessment; 1.
- Improved workflow decreased average time for typical assessment; 2.
-
- Decreased intra-observer variability of assessments; and
- Decreased inter-observer variability of assessments. 4.
Verification and validation testing concluded that the modified CMQ is safe and effective and introduced no new risks.
8) General Safety and Effectiveness Concerns
The device labeling contains operating instructions for the safe and effective use of the QLAB Quantification software with the modified CMQ plug-in.
9) Conclusions
Verification, validation, and testing activities, where required to establish the performance, functionality, and reliability characteristics of the modified device with respect to the predicate were performed. Testing involved system level tests, performance tests, and safety testing from hazard analysis. Testing performed demonstrates that the QLAB Quantification software with modified CMQ plug-in meets all defined reliability requirements and performance claims.
Page 2 of 2
Philips Ultrasound
2
DEPARTMENT OF HEALTH & HUMAN SERVICES
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room - WO66-G609 Silver Spring, MD 20993-0002
MAR - 9 2012
Philips Ultrasound, Inc. % Mr. Mark Job Responsible Third Party Regulatory Technology Services LLC 1394 25th Street NW BUFFALO MN 55313
Re: K120525
Trade/Device Name: Philips OLAB Quantification Software Regulation Number: 21 CFR 892.2050 Regulation Name: Picture archiving and communications system Regulatory Class: II Product Code: LLZ Dated: February 21, 2012 Received: February 22, 2012
Dear Mr. Job:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate 187 as career in to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into class II (Special Controls), it may be subject to such 11 your de ree to traces in the regulations affecting your device can be found in Title 21, additional controller Elizang (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean I lease be determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must or any I outer station of the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of
3
medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820). This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Parts 801 and 809), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely Yours,
Janine M. Morris
Acting Director Division of Radiological Devices Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
4
K120525 510(k) Number (if known):
Device Name: Philips QLAB Quantification Software
Indications for Use:
QLAB Quantification Software is a software application package. It is designed to view and quantify image data acquired on Philips Medical Systems ultrasound products.
Prescription Use X (Part 21 CFR 801 Subpart D) AND/OR
Over-the-counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)
Mary S. Postel
Division Sign-Off Office of In Vitro Diagnostic Device Evaluation and Safety